BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20487670)

  • 21. "Inactive" ingredients in oral medications.
    Reker D; Blum SM; Steiger C; Anger KE; Sommer JM; Fanikos J; Traverso G
    Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
    Ursino MG; Poluzzi E; Caramella C; De Ponti F
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organoleptic excipients used in pediatric antibiotics.
    Nakama KA; Dos Santos RB; Serpa P; Maciel TR; Haas SE
    Arch Pediatr; 2019 Oct; 26(7):431-436. PubMed ID: 31611144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic contact dermatitis to preservatives in topical medicaments.
    Skinner SL; Marks JG
    Am J Contact Dermat; 1998 Dec; 9(4):199-201. PubMed ID: 9810018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of colourings and preservatives in drugs.
    Pollock I; Young E; Stoneham M; Slater N; Wilkinson JD; Warner JO
    BMJ; 1989 Sep; 299(6700):649-51. PubMed ID: 2508849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation.
    Butler DC; Heller MM; Murase JE
    J Am Acad Dermatol; 2014 Mar; 70(3):417.e1-10; quiz 427. PubMed ID: 24528912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additives contained in drug formulations most frequently prescribed in Switzerland.
    Kolly M; Pécoud A; Frei PC
    Ann Allergy; 1989 Jan; 62(1):21-5. PubMed ID: 2912321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the food allergenic proteins contained in pharmaceutical excipients].
    Sakai S; Adachi R; Miyazaki T; Aso Y; Okuda H; Teshima R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2012; (130):58-65. PubMed ID: 23243989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American Academy of Pediatrics. "Inactive" ingredients in pharmaceutical products. Committee on Drugs.
    Pediatrics; 1985 Oct; 76(4):635-43. PubMed ID: 3900909
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic therapies containing ethanol and gelatine excipients.
    Laws PM; Warren RB
    Br J Dermatol; 2010 Oct; 163(4):885-6. PubMed ID: 20854406
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of error estimated from Palestine pharmacists' knowledge and certainty on the adverse effects and contraindications of active pharmaceutical ingredients and excipients.
    Shawahna R; Al-Rjoub M; Al-Horoub MM; Al-Hroub W; Al-Rjoub B; Al-Nabi BA
    J Educ Eval Health Prof; 2016; 13():1. PubMed ID: 26743774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent contact dermatitis. When a cause can't be found, consider the cure.
    Helms SE; Brodell RT; Bredle DL
    Postgrad Med; 1999 Apr; 105(4):220, 223-4. PubMed ID: 10223099
    [No Abstract]   [Full Text] [Related]  

  • 33. Developmental toxicity assessment of common excipients using a stem cell-based in vitro morphogenesis model.
    Yuan CJ; Marikawa Y
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):376-385. PubMed ID: 28927898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gluten in pills: a hazard for patients with celiac disease.
    Patel DG; Krogh CM; Thompson WG
    Can Med Assoc J; 1985 Jul; 133(2):114-5. PubMed ID: 4005755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact hypersensitivity to selected excipients of dermatological topical preparations and cosmetics in patients with chronic eczema.
    Dastychová E; Necas M; Vasku V
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Jun; 17(2):61-8. PubMed ID: 18709291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium metabisulfite allergy is common but is it relevant?
    Madan V; Walker SL; Beck MH
    Contact Dermatitis; 2007 Sep; 57(3):173-6. PubMed ID: 17680867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
    Murase JE; Heller MM; Butler DC
    J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of common pharmaceutical excipients on the gut microbiota.
    Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New formulations in dermatology].
    Fredon L; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S30-6. PubMed ID: 17563712
    [No Abstract]   [Full Text] [Related]  

  • 40. Lactose filler as a cause of "drug-induced" diarrhea.
    Lieb J; Kazienko DJ
    N Engl J Med; 1978 Aug; 299(6):314. PubMed ID: 661937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.